|
|
||||||||
in Type 1 Diabetes: Islet-Specific Expression Abrogates the Ongoing Autoimmune Process When Induced Late but Not Early During Pathogenesis1


*
Departments of Neuropharmacology and Immunology, The Scripps Research Institute, La Jolla, CA 92037; and
Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520
We report here that islet-specific expression of TNF-
can play a
dual role in autoimmune diabetes, depending on its precise timing in
relation to the ongoing autoimmune process. In a transgenic model (rat
insulin promoter-lymphocytic choriomeningitis virus) of virally induced
diabetes, TNF-
enhanced disease incidence when induced through an
islet-specific tetracycline-dependent promoter system early during
pathogenesis. Blockade of TNF-
during this phase prevented diabetes
completely, suggesting its pathogenetic importance early in disease
development. In contrast, TNF-
expression abrogated the autoimmune
process when induced late, which was associated with a reduction of
autoreactive CD8 lymphocytes in islets and their lytic activities.
Thus, the fine-tuned kinetics of an autoreactive process undergo
distinct stages that respond in a differential way to the presence of
TNF-
. This observation has importance for understanding the complex
role of inflammatory cytokines in autoimmunity.
This article has been cited by other articles:
![]() |
M. Y. Donath, J. Storling, L. A. Berchtold, N. Billestrup, and T. Mandrup-Poulsen Cytokines and {beta}-Cell Biology: from Concept to Clinical Translation Endocr. Rev., May 1, 2008; 29(3): 334 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Singh and M. Suresh A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory J. Leukoc. Biol., November 1, 2007; 82(5): 1201 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rotondi, L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani Role of Chemokines in Endocrine Autoimmune Diseases Endocr. Rev., August 1, 2007; 28(5): 492 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D Tran, S. Kodama, B. M Lodde, I. Szalayova, S. Key, S. Khalili, D. L Faustman, and E. Mezey Reversal of Sjogren's-like syndrome in non-obese diabetic mice Ann Rheum Dis, June 1, 2007; 66(6): 812 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Charo and P. F. Robbins Contrasting effects of FLIPL overexpression in human T cells on activation-induced cell death and cytokine production J. Leukoc. Biol., May 1, 2007; 81(5): 1297 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dotta, S. Censini, A. G. S. van Halteren, L. Marselli, M. Masini, S. Dionisi, F. Mosca, U. Boggi, A. O. Muda, S. D. Prato, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients PNAS, March 20, 2007; 104(12): 5115 - 5120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stosic-Grujicic, I. Cvetkovic, K. Mangano, M. Fresta, D. Maksimovic-Ivanic, L. Harhaji, D. Popadic, M. Momcilovic, D. Miljkovic, J. Kim, et al. A Potent Immunomodulatory Compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxasole Acetic Acid, Prevents Spontaneous and Accelerated Forms of Autoimmune Diabetes in NOD Mice and Inhibits the Immunoinflammatory Diabetes Induced by Multiple Low Doses of Streptozotocin in CBA/H Mice J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1038 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Gurr, M. Shaw, Y. Li, and R. Sherwin RegII Is a {beta}-Cell Protein and Autoantigen in Diabetes of NOD Mice Diabetes, January 1, 2007; 56(1): 34 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Fujinami, M. G. von Herrath, U. Christen, and J. L. Whitton Molecular Mimicry, Bystander Activation, or Viral Persistence: Infections and Autoimmune Disease Clin. Microbiol. Rev., January 1, 2006; 19(1): 80 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zakharova and H. K. Ziegler Paradoxical Anti-Inflammatory Actions of TNF-{alpha}: Inhibition of IL-12 and IL-23 via TNF Receptor 1 in Macrophages and Dendritic Cells J. Immunol., October 15, 2005; 175(8): 5024 - 5033. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Christen and M. G. von Herrath Infections and Autoimmunity--Good or Bad? J. Immunol., June 15, 2005; 174(12): 7481 - 7486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suresh, A. Singh, and C. Fischer Role of Tumor Necrosis Factor Receptors in Regulating CD8 T-Cell Responses during Acute Lymphocytic Choriomeningitis Virus Infection J. Virol., January 1, 2005; 79(1): 202 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Qin, P. Chaturvedi, and B. Singh In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-{gamma}/TNF-{alpha} Int. Immunol., December 1, 2004; 16(12): 1723 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, S. Hussain, Q.-S. Mi, P. Santamaria, and T. L. Delovitch Perturbed Homeostasis of Peripheral T Cells Elicits Decreased Susceptibility to Anti-CD3-Induced Apoptosis in Prediabetic Nonobese Diabetic Mice J. Immunol., October 1, 2004; 173(7): 4407 - 4416. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Juedes, E. Rodrigo, L. Togher, L. H. Glimcher, and M. G. von Herrath T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes J. Exp. Med., April 19, 2004; 199(8): 1153 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Christen, R. Darwiche, H. E. Thomas, T. Wolfe, E. Rodrigo, A. Chervonsky, R. A. Flavell, and M. G. von Herrath Virally Induced Inflammation Triggers Fratricide of Fas-Ligand-Expressing {beta}-Cells Diabetes, March 1, 2004; 53(3): 591 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Christen, D. B. McGavern, A. D. Luster, M. G. von Herrath, and M. B. A. Oldstone Among CXCR3 Chemokines, IFN-{gamma}-Inducible Protein of 10 kDa (CXC Chemokine Ligand (CXCL) 10) but Not Monokine Induced by IFN-{gamma} (CXCL9) Imprints a Pattern for the Subsequent Development of Autoimmune Disease J. Immunol., December 15, 2003; 171(12): 6838 - 6845. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fujita, J. M. Shannon, O. Morikawa, J. Gauldie, N. Hara, and R. J. Mason Overexpression of Tumor Necrosis Factor-{alpha} Diminishes Pulmonary Fibrosis Induced by Bleomycin or Transforming Growth Factor-{beta} Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 669 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Grohmann, F. Fallarino, R. Bianchi, C. Orabona, C. Vacca, M. C. Fioretti, and P. Puccetti A Defect in Tryptophan Catabolism Impairs Tolerance in Nonobese Diabetic Mice J. Exp. Med., July 7, 2003; 198(1): 153 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Wu, H. Hua, S. H. Munson, and H. O. McDevitt Tumor necrosis factor-alpha regulation of CD4+C25+ T cell levels in NOD mice PNAS, September 17, 2002; 99(19): 12287 - 12292. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. CHRISTEN and M. G. VON HERRATH Apoptosis of Autoreactive CD8 Lymphocytes as a Potential Mechanism for the Abrogation of Type 1 Diabetes by Islet-Specific TNF-{alpha} Expression at a Time When the Autoimmune Process Is Already Ongoing Ann. N.Y. Acad. Sci., April 1, 2002; 958(1): 166 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. von Herrath, B. Coon, T. Wolfe, and L. Chatenoud Nonmitogenic CD3 Antibody Reverses Virally Induced (Rat Insulin Promoter-Lymphocytic Choriomeningitis Virus) Autoimmune Diabetes Without Impeding Viral Clearance J. Immunol., January 15, 2002; 168(2): 933 - 941. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |